Jing Liao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jing Liao has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Liyuan Mm Bei
Nephrology Department, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China
2 shared publications - Pinjing Liu
Ruikang Hospital, Affiliated to Guangxi University of Traditional Chinese Medicine, Nanning, China
2 shared publications - Yongquan Zhang
Ruikang Hospital, Affiliated to Guangxi University of Traditional Chinese Medicine, Nanning, China
2 shared publications - Zhenhua Yang
Nephrology Department, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China
2 shared publications - Chunlan Mm Tan
Nephrology Department, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China
1 shared publication - Ling Lei
Department of Rheumatology and Immunology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China
1 shared publication
Latest Publications
- Open Access
- 8 May 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (19) , e48687
Mendelian randomization analysis links HLA-DR+ CD14− CD16+ monocytes to CCL19-driven ankylosing spondylitis risk
Ankylosing spondylitis (AS), strongly linked to human leukocyte antigen (HLA)-B27, lacks effective treatments for many patients despite biologics. This study investigated causal links between immune cells, inflammatory proteins, and AS to identify new therapeutic targets using genetic methods. Mendelian randomization (MR) analysis was applied using large-scale genetic data. Immune cell data came from Vuckovic et al and Orrù et al, AS data from FinnGen, and inflammatory protein data from Zhao et al. Two-sample MR explored causal relationships, and mediation analysis assessed whether proteins mediated immune cell effects on AS. MR analysis identified 26 immune cell phenotypes associated with AS, with HLA DR+ CD14− CD16+ monocytes showing the strongest protective effect (odds ratio = 0.6423). Among the 5 associated inflammatory proteins, C-C motif chemokine 19 (CCL19) had the most substantial effect on AS risk (odds ratio = 2.4234). Mediation analysis revealed that HLA DR+ CD14− CD16+ monocytes influence AS risk by reducing CCL19 levels, with the proportion of the mediated effect was 17.98% (95% confidence interval = 8.23%–27.72%). Our findings suggest that HLA DR+ CD14− CD16+ monocytes are associated with a reduced risk of AS, as indicated by a negative causal effect (β = −0.4426). This protective effect is partially mediated by a decrease in CCL19 levels, a chemokine that, when elevated, increases AS risk. These results identify CCL19 and this monocyte subset as potential key players in AS pathogenesis and highlight them as promising targets for more effective, personalized therapies.
- 8 May 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (19) , e48687
Open AccessMendelian randomization analysis links HLA-DR+ CD14− CD16+ monocytes to CCL19-driven ankylosing spondylitis risk
Ankylosing spondylitis (AS), strongly linked to human leukocyte antigen (HLA)-B27, lacks effective treatments for many patients despite biologics. This study investigated causal links between immune cells, inflammatory proteins, and AS to identify new therapeutic targets using genetic methods. Mendelian randomization (MR) analysis was applied using large-scale genetic data. Immune cell data came from Vuckovic et al and Orrù et al, AS data from FinnGen, and inflammatory protein data from Zhao et al. Two-sample MR explored causal relationships, and mediation analysis assessed whether proteins mediated immune cell effects on AS. MR analysis identified 26 immune cell phenotypes associated with AS, with HLA DR+ CD14− CD16+ monocytes showing the strongest protective effect (odds ratio = 0.6423). Among the 5 associated inflammatory proteins, C-C motif chemokine 19 (CCL19) had the most substantial effect on AS risk (odds ratio = 2.4234). Mediation analysis revealed that HLA DR+ CD14− CD16+ monocytes influence AS risk by reducing CCL19 levels, with the proportion of the mediated effect was 17.98% (95% confidence interval = 8.23%–27.72%). Our findings suggest that HLA DR+ CD14− CD16+ monocytes are associated with a reduced risk of AS, as indicated by a negative causal effect (β = −0.4426). This protective effect is partially mediated by a decrease in CCL19 levels, a chemokine that, when elevated, increases AS risk. These results identify CCL19 and this monocyte subset as potential key players in AS pathogenesis and highlight them as promising targets for more effective, personalized therapies.
- Open Access
- 10 February 2026
- Published by Taylor & Francis in Renal Failure
- Vol. 48 (1) , 2624286
Integrative transcriptomic and machine learning analysis identifies PYCARD and IFI30 as immune-lysosomal biomarkers of ANCA-associated glomerulonephritis
ANCA-associated glomerulonephritis (ANCA-GN) is an immune-mediated kidney disease leading to acute or chronic renal failure. This study investigates the role of mitophagy-related genes in ANCA-GN, as mitochondrial dysfunction is closely linked to the pathogenesis of various kidney diseases. This study analyzed transcriptomic data from GEO datasets (GSE104948 and GSE108109) to investigate mitophagy-related mechanisms in ANCA-GN. Methods included batch correction, consensus clustering (identifying two subtypes), weighted gene co-expression network analysis (WGCNA), differential expression screening, and machine learning (LASSO, random forest, SVM-RFE). A diagnostic nomogram was constructed and validated, and immune cell infiltration was profiled. Analyses revealed distinct activation of immune pathways, including complement and phagosome signaling, alongside abnormal infiltration of CD8+ T cells in ANCA-GN. Subtype-specific analysis identified 131 differentially expressed genes (DEGs), while 143 DEGs distinguished ANCA-GN from controls.Intersection analysis and machine learning prioritized two hub genes, PYCARD and IFI30, which exhibited strong diagnostic accuracy (AUC >0.9) and correlated with CD8+ T-cell infiltration. A nomogram model validated their clinical utility (AUC >0.9). Functional enrichment highlighted phagocytosis and immune signaling pathways. Immune profiling revealed significant upregulation of 20 immune cell types in ANCA-GN. These findings suggest that mitophagy-immune crosstalk drives ANCA-GN progression, with PYCARD and IFI30 as potential diagnostic biomarkers. This study provides mechanistic insights into ANCA-GN pathogenesis and proposes novel targets for clinical intervention.
- 10 February 2026
- Published by Taylor & Francis in Renal Failure
- Vol. 48 (1) , 2624286
Open AccessIntegrative transcriptomic and machine learning analysis identifies PYCARD and IFI30 as immune-lysosomal biomarkers of ANCA-associated glomerulonephritis
ANCA-associated glomerulonephritis (ANCA-GN) is an immune-mediated kidney disease leading to acute or chronic renal failure. This study investigates the role of mitophagy-related genes in ANCA-GN, as mitochondrial dysfunction is closely linked to the pathogenesis of various kidney diseases. This study analyzed transcriptomic data from GEO datasets (GSE104948 and GSE108109) to investigate mitophagy-related mechanisms in ANCA-GN. Methods included batch correction, consensus clustering (identifying two subtypes), weighted gene co-expression network analysis (WGCNA), differential expression screening, and machine learning (LASSO, random forest, SVM-RFE). A diagnostic nomogram was constructed and validated, and immune cell infiltration was profiled. Analyses revealed distinct activation of immune pathways, including complement and phagosome signaling, alongside abnormal infiltration of CD8+ T cells in ANCA-GN. Subtype-specific analysis identified 131 differentially expressed genes (DEGs), while 143 DEGs distinguished ANCA-GN from controls.Intersection analysis and machine learning prioritized two hub genes, PYCARD and IFI30, which exhibited strong diagnostic accuracy (AUC >0.9) and correlated with CD8+ T-cell infiltration. A nomogram model validated their clinical utility (AUC >0.9). Functional enrichment highlighted phagocytosis and immune signaling pathways. Immune profiling revealed significant upregulation of 20 immune cell types in ANCA-GN. These findings suggest that mitophagy-immune crosstalk drives ANCA-GN progression, with PYCARD and IFI30 as potential diagnostic biomarkers. This study provides mechanistic insights into ANCA-GN pathogenesis and proposes novel targets for clinical intervention.
- 15 March 2025
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62 (7) , 9162-9169
DNA Methylation-Regulated ZDHHC13 Promotes the Progression of Parkinson’s Disease
Recent studies suggest that palmitoylation may influence proteins involved in neurotransmission and neurodegenerative changes, such as pathological α-synuclein. However, the role of palmitoylation in Parkinson’s disease (PD) has not been systematically investigated. Additionally, findings on DNA methylation changes and PD-associated gene expression remain inconsistent. This study aims to explore the causal relationship and mechanisms between palmitoylation genes, DNA methylation, and PD using Mendelian Randomization (MR). This study employed two-sample MR analysis, summary-data-based Mendelian Randomization (SMR) analysis, and mediation analysis, utilizing PD GWAS data from the Finngen database, palmitoylation genes data from the eQTLGen database, and DNA methylation data from the GoDMC database. First, a two-sample MR analysis was used to evaluate the causal relationship between the palmitoylation genes and PD. Then, the SMR method was applied to validate the association between gene expression and PD. Finally, mediation analysis was conducted to explore the mediating effect of DNA methylation on the relationship between expression of palmitoylation genes and PD. Our study found a significant positive correlation between high expression of the ZDHHC13 gene and increased PD risk. Each 1 standard deviation increase in ZDHHC13 expression was associated with a 24.20% increase in PD risk. Further DNA methylation analysis identified two key methylation sites (cg00161556 and cg27379915), which indirectly influenced the occurrence of PD by regulating the expression of the ZDHHC13 gene. Mediation effect analysis revealed that the methylation sites cg00161556 and cg27379915 indirectly promoted the development of PD by regulating the expression of the ZDHHC13 gene, with the mediation effect of ZDHHC13 gene expression accounting for 63.72% and 57.61% of the total effect, respectively. Sensitivity analysis and SMR analysis supported our findings, indicating high statistical robustness. This study highlights the role of DNA methylation in regulating ZDHHC13 during PD progression, suggesting potential clinical applications such as ZDHHC13 as a biomarker or therapeutic target for early PD diagnosis and treatment.
- 15 March 2025
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62 (7) , 9162-9169
DNA Methylation-Regulated ZDHHC13 Promotes the Progression of Parkinson’s Disease
Recent studies suggest that palmitoylation may influence proteins involved in neurotransmission and neurodegenerative changes, such as pathological α-synuclein. However, the role of palmitoylation in Parkinson’s disease (PD) has not been systematically investigated. Additionally, findings on DNA methylation changes and PD-associated gene expression remain inconsistent. This study aims to explore the causal relationship and mechanisms between palmitoylation genes, DNA methylation, and PD using Mendelian Randomization (MR). This study employed two-sample MR analysis, summary-data-based Mendelian Randomization (SMR) analysis, and mediation analysis, utilizing PD GWAS data from the Finngen database, palmitoylation genes data from the eQTLGen database, and DNA methylation data from the GoDMC database. First, a two-sample MR analysis was used to evaluate the causal relationship between the palmitoylation genes and PD. Then, the SMR method was applied to validate the association between gene expression and PD. Finally, mediation analysis was conducted to explore the mediating effect of DNA methylation on the relationship between expression of palmitoylation genes and PD. Our study found a significant positive correlation between high expression of the ZDHHC13 gene and increased PD risk. Each 1 standard deviation increase in ZDHHC13 expression was associated with a 24.20% increase in PD risk. Further DNA methylation analysis identified two key methylation sites (cg00161556 and cg27379915), which indirectly influenced the occurrence of PD by regulating the expression of the ZDHHC13 gene. Mediation effect analysis revealed that the methylation sites cg00161556 and cg27379915 indirectly promoted the development of PD by regulating the expression of the ZDHHC13 gene, with the mediation effect of ZDHHC13 gene expression accounting for 63.72% and 57.61% of the total effect, respectively. Sensitivity analysis and SMR analysis supported our findings, indicating high statistical robustness. This study highlights the role of DNA methylation in regulating ZDHHC13 during PD progression, suggesting potential clinical applications such as ZDHHC13 as a biomarker or therapeutic target for early PD diagnosis and treatment.
- 25 January 2024
- Published by Springer Nature in Neurological Sciences
- Vol. 45 (7) , 3117-3124
Causal relationships between peripheral immune cells and Alzheimer’s disease: a two-sample Mendelian randomization study
Objective Previous research suggests that peripheral immune cells may play a role in the development of Alzheimer's disease (AD). Our study aims to determine if the composition of peripheral immune cells directly contributes to the occurrence of AD. Methods We utilized a two-sample Mendelian randomization (MR) approach to examine the association between peripheral immune cells and AD.The primary analysis method used was the inverse variance weighted (IVW) method, and we also conducted analyses using MR Egger, weighted median, simple mode, and weighted mode methods to ensure the accuracy of the results.Heterogeneity and horizontal pleiotropy were evaluated using Cochran's Q statistics and the MR Egger intercept, respectively. Results The study found a significant correlation between increased IgD + CD24- AC cells (Odds Ratio [OR] = 1.03, 95% Confidence Interval [CI] = 1.01–1.06, P = 0.0172), increased CD4 + %leukocyte (OR = 1.08, 95% CI = 1.02–1.14, P = 0.0086), and increased CD4 + CD8dim AC cells (OR = 1.06, 95% CI = 1.01–1.11, P = 0.0218), with an increased susceptibility to AD. Conversely, an increase in EM DN (CD4-CD8-) %T cells (OR = 0.95, 95% CI = 0.92–0.99, P = 0.0164) and an increase in DN (CD4-CD8-) AC cells (OR = 0.93, 95% CI = 0.88–0.99, P = 0.0145) were associated with a protective effect against AD. Conclusion Our findings establish a causal link between peripheral immune cells and AD. This study is the first to examine the relationship between peripheral immune cells and AD using MR, offering valuable insights for early diagnosis and treatment decisions.
- 25 January 2024
- Published by Springer Nature in Neurological Sciences
- Vol. 45 (7) , 3117-3124
Causal relationships between peripheral immune cells and Alzheimer’s disease: a two-sample Mendelian randomization study
Objective Previous research suggests that peripheral immune cells may play a role in the development of Alzheimer's disease (AD). Our study aims to determine if the composition of peripheral immune cells directly contributes to the occurrence of AD. Methods We utilized a two-sample Mendelian randomization (MR) approach to examine the association between peripheral immune cells and AD.The primary analysis method used was the inverse variance weighted (IVW) method, and we also conducted analyses using MR Egger, weighted median, simple mode, and weighted mode methods to ensure the accuracy of the results.Heterogeneity and horizontal pleiotropy were evaluated using Cochran's Q statistics and the MR Egger intercept, respectively. Results The study found a significant correlation between increased IgD + CD24- AC cells (Odds Ratio [OR] = 1.03, 95% Confidence Interval [CI] = 1.01–1.06, P = 0.0172), increased CD4 + %leukocyte (OR = 1.08, 95% CI = 1.02–1.14, P = 0.0086), and increased CD4 + CD8dim AC cells (OR = 1.06, 95% CI = 1.01–1.11, P = 0.0218), with an increased susceptibility to AD. Conversely, an increase in EM DN (CD4-CD8-) %T cells (OR = 0.95, 95% CI = 0.92–0.99, P = 0.0164) and an increase in DN (CD4-CD8-) AC cells (OR = 0.93, 95% CI = 0.88–0.99, P = 0.0145) were associated with a protective effect against AD. Conclusion Our findings establish a causal link between peripheral immune cells and AD. This study is the first to examine the relationship between peripheral immune cells and AD using MR, offering valuable insights for early diagnosis and treatment decisions.